Fig. 3
From: Identification of oxylipins and lipid mediators in pulmonary embolism
Receiver operating characteristic (ROC) curves of patients with PE (n = 555), comprising the survival group (n = 513) and the non-survival group (n = 42), alongside the HC group (n = 200). (A) ROC curve of serum TC for distinguishing patients with PE from HCs. (B) ROC curve of serum HDL-C for distinguishing patients with PE from HCs. (C) ROC curve of serum LDL-C for distinguishing patients with PE from HCs. (D) ROC curve of serum apoA for distinguishing patients with PE from HCs. (E) ROC curve of serum TG for distinguishing patients with PE from HCs. (F) ROC curve of serum D-dimer for distinguishing patients with PE from HCs. (G) ROC joint diagnostic analysis of serum TC, HDL-C, LDL-C, and apoA for distinguishing patients with PE from HCs. (H) ROC joint diagnostic analysis of serum TC, HDL-C, LDL-C, apoA, and serum D-dimer for distinguishing patients with PE from HCs. (I) ROC curve of serum HDL-C for distinguishing between the PE nonsurviving group and the survival group. (J) ROC curve of serum apoA for distinguishing between the PE nonsurviving group and the survival group. (K) ROC joint diagnostic analysis of serum HDL-C and apoA for distinguishing between the PE nonsurviving group and the survival group
Abbreviations: HC: healthy control; PE: pulmonary embolism; TC: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; apoA: apolipoprotein A1; apoB: apolipoprotein B; TG: triglyceride